Poly PPT SER(06049): Wang Yingnan appointed as executive director.

17:30 13/03/2026

Poly Property (06049) announced that Mr. Wang Yingnan has been appointed as an executive director, with a term from the end of the temporary shareholders' meeting to the end of the term of the third board of directors. On the same day, the board of directors appointed Mr. Wang Yingnan as a member of the Strategic and Sustainable Development Committee in accordance with the board resolution of January 27, 2026. His term is consistent with the term of the third board of directors after being approved by the shareholders at the temporary shareholders' meeting.

POLY PPT SER (06049) announced that Mr. Wang Yingnan has been appointed as an executive director, with a term from the end of the temporary shareholders meeting until the completion of the term of office of the third board of directors. On the same day, the board of directors, in accordance with the resolution of the board of directors on January 27, 2026, appointed Mr. Wang Yingnan as a member of the Strategic and Sustainable Development Committee, with a term consistent with that of the third board of directors.

CMS(00867): The new drug De-Xi-Du-Si-Ta tablets for renal anemia has been approved for market in China.

New Stock News: Changguang Chenxin's Hong Kong IPO and domestic unlisted shares have been approved by the China Securities Regulatory Commission for "full circulation".

SUNSHINE PHARMA (06887) announces a profit, with an expected annual net profit attributable to the parent of about 270 million yuan in 2025, turning from a loss to a profit compared to the previous year.

CMS(00867): The new drug De-Xi-Du-Si-Ta tablets for renal anemia has been approved for market in China.

New Stock News: Changguang Chenxin's Hong Kong IPO and domestic unlisted shares have been approved by the China Securities Regulatory Commission for "full circulation".